BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Extended-release tacrolimus (VI-0106) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Extended-release tacrolimus (VI-0106)\, f
 rom ClinicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07612657-549@assetmemo.bio
DTSTAMP:20261121T005011Z
DTSTART;VALUE=DATE:20280531
DTEND;VALUE=DATE:20280601
SUMMARY:Extended-release tacrolimus (VI-0106): Phase 3 readout est. (NCT076
 12657)
DESCRIPTION:Extended-release tacrolimus (VI-0106)\, phase 3\, Pulmonary Art
 erial Hypertension.\nStudy: A Phase 3 Study of Extended-release Tacrolimus
  in Subjects With Pulmonary Arterial Hypertension and Functional Limitatio
 ns\nEstimated primary completion: 31 May 2028. This is a ClinicalTrials.go
 v estimate\, not a confirmed readout date\, and it can move.\nDrug page: h
 ttps://assetmemo.bio/drug/extended-release-tacrolimus-vi-0106#upcoming-eve
 nts\nRegistry record: https://clinicaltrials.gov/study/NCT07612657
URL:https://assetmemo.bio/drug/extended-release-tacrolimus-vi-0106#upcoming
 -events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
